Mendonça Nuno, Manageiro Vera, Robin Frédéric, Salgado M José, Ferreira Eugénia, Caniça Manuela, Bonnet Richard
Antibiotic Resistance Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Antimicrob Agents Chemother. 2008 May;52(5):1806-11. doi: 10.1128/AAC.01381-07. Epub 2008 Mar 3.
The new beta-lactamase SHV-72 was isolated from clinical Klebsiella pneumoniae INSRA1229, which exhibited the unusual association of resistance to the amoxicillin-clavulanic acid combination (MIC, 64 microg/ml) and susceptibility to cephalosporins, aztreonam, and imipenem. SHV-72 (pI 7.6) harbored the three amino acid substitutions Ile8Phe, Ala146Val, and Lys234Arg. SHV-72 had high catalytic efficiency against penicillins (k(cat)/K(m), 35 to 287 microM(-1) x s(-1)) and no activity against oxyimino beta-lactams. The concentration of clavulanic acid necessary to inhibit the enzyme activity by 50% was 10-fold higher for SHV-72 than for SHV-1. Molecular-dynamics simulation suggested that the Lys234Arg substitution in SHV-72 stabilized an atypical conformation of the Ser130 side chain, which moved the O gamma atom of Ser130 around 3.5 A away from the key O gamma atom of the reactive serine (Ser70). This movement may therefore decrease the susceptibility to clavulanic acid by preventing cross-linking between Ser130 and Ser70.
新型β-内酰胺酶SHV-72是从临床肺炎克雷伯菌INSRA1229中分离得到的,该菌株表现出对阿莫西林-克拉维酸组合耐药(MIC为64μg/ml)但对头孢菌素、氨曲南和亚胺培南敏感这种不寻常的情况。SHV-72(pI 7.6)存在三个氨基酸替换,即Ile8Phe、Ala146Val和Lys234Arg。SHV-72对青霉素具有较高的催化效率(k(cat)/K(m),35至287μM⁻¹×s⁻¹),而对氧亚氨基β-内酰胺无活性。抑制SHV-72酶活性50%所需的克拉维酸浓度比SHV-1高10倍。分子动力学模拟表明,SHV-72中的Lys234Arg替换稳定了Ser130侧链的非典型构象,使Ser130的Oγ原子从反应性丝氨酸(Ser70)的关键Oγ原子处移开约3.5 Å。因此,这种移动可能通过阻止Ser130和Ser70之间的交联而降低对克拉维酸的敏感性。